10/09/2026
Discover Industry-Sponsored Product Theaters at the 55th CNS Annual Meeting in Montrรฉal, Quรฉbec, Canada, featuring new therapies, tools, and diagnostic approaches.
๐ง๐ต๐๐ฟ๐๐ฑ๐ฎ๐, ๐ข๐ฐ๐๐ผ๐ฏ๐ฒ๐ฟ ๐ญ๐ฑ
11:45 AM โ 1:15 PM ET
๐ง Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment with Acadia Pharmaceuticals Inc.
๐ง Recognizing the Unexpected: Expanding the Differential in Pediatric Neuromuscular Disease with UCB, Inc.
6:30-7:30 PM ET
๐ง Modern VNS Therapy for Drug-Resistant Epilepsy: From Advanced Features to Improved Outcomes with LivaNova USA, Inc.
๐ง Beyond Medication: Integrating REN into Pediatric Migraine Care with Theranica USA, Inc.
๐๐ฟ๐ถ๐ฑ๐ฎ๐, ๐ข๐ฐ๐๐ผ๐ฏ๐ฒ๐ฟ ๐ญ๐ฒ
11:00 AM-1:00 PM ET
๐ง Understanding Mechanism of Disease and Progression in DMD with ITF Therapeutics
๐ง A Clinical Genome Built with Intention with Ambry Genetics
Add these Product Theaters to your CNS 2026 plans. Visit the link in bio to view the full program and pre-register today: https://ow.ly/5Vp250ZVAqT